US-based healthcare technology company Syllable has acquired Actium Health, which specialises in AI-driven patient data analysis for healthcare marketing and engagement.
The financial terms of the deal have not been disclosed.
Actium Health offers the CENTARI platform, which uses AI to predict and prioritise patients’ medical service needs, including care gaps and risk progression.
The company claims that its technology has helped more than 20 million patients receive necessary care and resulted in 1,395 early breast cancer diagnoses.
Syllable CEO Kobus Jooste said: “With US healthcare consumers prioritising ‘ease of using healthcare services,’ the role Actium Health will play in Syllable’s portfolio is crucial to Syllable’s mission to revolutionise healthcare.
“We welcome the Actium Health team, and look forward to increasing the value we provide to health systems.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataActium Health will now be a division within Syllable, continuing to focus on leveraging clinical propensity models to improve patient engagement and healthcare outcomes.
Actium Health’s clients include Nuvance Health, Legacy Health, Virtua Health and Catholic Health System of Long Island.
Syllable’s AI solutions, including its multilingual, 24/7 AI-powered platform Patient Assistant, are designed to help improve the patient experience.
Patient Assistant uses natural language processing (NLP) and HIPAA-compliant AI to automate more than 70% of hospital calls and ensure that more callers reach their intended destination.
The company’s solutions are designed to optimise patient volume and capacity, reduce staff burden and improve patient access, particularly for those at high risk of conditions such as breast cancer and heart disease.
Through the acquisition, Syllable aims to improve its AI offerings for health systems by integrating Actium Health’s patient activation solution.
Actium Health founder and CEO Michael Linnert said: “Together with Syllable, we now have an end-to-end solution that allows patients to navigate health systems, schedule appointments, refill prescriptions, and more, all in an automated way either digitally or on the phone.”